Comparative efficacy of TAS-102 and chemotherapy rechallenge in the third-line setting and beyond in patients with advanced colorectal cancer: A retrospective study.

被引：0
|
作者：
Alanazi, Rakan
Alotaibi, Khalid
Ali, Murtada Mohamed
Abushara, Ahmed
Albahrani, Zainab
Alsehali, Afrah
Almesfir, Reem
Alsubaie, Razan
Alkaiyat, Mohammad
Shehata, Husam
Sabatin, Fouad
Algarni, Mohammed Ahmed
机构：
[1] Minist Natl Guard Hlth Affairs, Oncol Dept, Riyadh, Saudi Arabia
[2] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[3] Minist Natl Guard Hlth Affairs, Dept Oncol, Riyadh, Saudi Arabia
[4] Minist Natl Guard Hlth Affairs, Dept Oncol, King Abdulaziz Med City, Riyadh, Saudi Arabia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.78
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
78
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [41] Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
    Johanna C. Bendell
    Lee S. Rosen
    Robert J. Mayer
    Jonathan W. Goldman
    Jeffrey R. Infante
    Fabio Benedetti
    Donghu Lin
    Hirokazu Mizuguchi
    Christopher Zergebel
    Manish R. Patel
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 925 - 932
  • [42] Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
    Bendell, Johanna C.
    Rosen, Lee S.
    Mayer, Robert J.
    Goldman, Jonathan W.
    Infante, Jeffrey R.
    Benedetti, Fabio
    Lin, Donghu
    Mizuguchi, Hirokazu
    Zergebel, Christopher
    Patel, Manish R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (05) : 925 - 932
  • [43] Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study
    Do Hyoung Lim
    Young Suk Park
    Byeong-Bae Park
    Sang Hoon Ji
    Jeeyun Lee
    Keon Woo Park
    Jung Hoon Kang
    Se-Hoon Lee
    Joon Oh Park
    Kihyun Kim
    Won Seog Kim
    Chul Won Jung
    Young-Hyuck Im
    Won Ki Kang
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 10 - 14
  • [44] Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer under oral trifluridine-tipiracil (TAS-102) chemotherapy
    Kimura, M.
    Usami, E.
    Iwai, M.
    Teramachi, H.
    Yoshimura, T.
    PHARMAZIE, 2017, 72 (01): : 49 - 52
  • [45] Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
    Elif Şenocak Taşçı
    Başak Oyan
    Özlem Sönmez
    Arda Ulaş Mutlu
    Muhammed Mustafa Atcı
    Abdullah Sakin
    İrem Öner
    Havva Yeşil Çınkır
    Melek Karakurt Eryılmaz
    Dilek Çağlayan
    Onur Yazdan Balçık
    Nail Paksoy
    Senem Karabulut
    Derya Kıvrak Salim
    Cemil Bilir
    Miraç Özen
    Melike Özçelik
    Ali Arıcan
    Baran Akagündüz
    Ali İnal
    Dinçer Aydın
    Leyla Özer
    Ahmet Gülmez
    Nazım Serdar Turhal
    Selin Aktürk Esen
    Efnan Algın
    Sinem Akbaş
    Yakup İriağaç
    Teoman Şakalar
    Çağlar Ünal
    Özlem Er
    Şaban Seçmeler
    Mustafa Bozkurt
    BMC Cancer, 24
  • [46] Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study
    Lim, DH
    Park, YS
    Park, BB
    Ji, SH
    Lee, J
    Park, KW
    Kang, JH
    Lee, SH
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Im, YH
    Kang, WK
    Park, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) : 10 - 14
  • [47] A real-world study: Efficacy of the third-line therapy of standard therapy versus rechallenge-chemotherapy in refractory metastatic colorectal cancer
    Xu, X.
    Fu, J.
    Xu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S49 - S49
  • [48] First report: A retrospective trial for evaluating the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer: HGCSG1503
    Masayoshi, Dazai
    Satoshi, Yuki
    Hiroshi, Nakatsumi
    Yasushi, Tsuji
    Yoshimitsu, Kobayashi
    Kazuteru, Hatanaka
    Hiroyuki, Okuda
    Ayumu, Hosokawa
    Koichi, Furukawa
    Kohei, Ogawa
    Shinya, Minami
    Atsushi, Ishiguro
    Takuya, Honda
    Tomoyuki, Ohta
    Kazunori, Eto
    Takashi, Kato
    Junta, Nakajima
    Takahide, Sasaki
    Michio, Nakamura
    Yoshiaki, Shindo
    Yuh, Sakata
    Yoshito, Komatsu
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Efficacy and safety of nivolumab and irinotecan as third-line chemotherapy for advanced gastric cancer: A multi-institutional retrospective study
    Kumanishi, Ryosuke
    Mitani, Seiichiro
    Kadowaki, Shigenori
    Matsushima, Tomohiro
    Takahashi, Naoki
    Ogata, Takatsugu
    Yasui, Hisateru
    Ogata, Misato
    Satake, Hironaga
    Narita, Yukiya
    Masuishi, Toshiki
    Bando, Hideaki
    Hara, Hiroki
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index
    Hatanaka, K.
    Yuki, S.
    Nakano, S.
    Sawada, K.
    Harada, K.
    Okuda, H.
    Ando, T.
    Ogawa, K.
    Furukawa, K.
    Minami, S.
    Saiki, T.
    Ohta, T.
    Kato, T.
    Nakajima, J.
    Sasaki, T.
    Saitoh, S.
    Shindo, Y.
    Tateyama, M.
    Kato, S.
    Nagai, H.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29
12345